Variations in blood pressure and lipid goal attainment in primary care

References

• Roger VL, Go AS, Lloyd-Jones DM, et al. Heart disease and stroke statistics – 2012 update: a report from the American Heart Association. Circulation 2012;125:e2-220
   PubMed Web of Science ®Google Scholar
• Johnson ML, Pietz K, Battleman DS, et al. Prevalence of comorbid hypertension and dyslipidemia and associated cardiovascular disease. Am J Manag Care 2004;10:926-32
   PubMed Web of Science ®Google Scholar
• Cooke CE, Robertson TA. Hypertension and lipids, retrospective analysis of comorbid hypertension and dyslipidemia management in a primary care practice, 2007. Available at: http://www.priory.com/fam.htm [Last assessed 20 January 2012]
   Google Scholar
• Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97
   Google Scholar
• Ferdinand KC, Kleinpeter, MA. Management of hypertension and dyslipidemia. Curr Hypertens Rep 2006;8:489-96
   PubMed Web of Science ®Google Scholar
• SHEP Cooperative Research Group. Prevention of stroke drug treatment in older persons with isolates systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-64
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris, GL, Black HR, et al. and the National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003;289:2560-71
   PubMed Web of Science ®Google Scholar
• Clinical reality of coronary prevention guidelines: a comparison of EUROASPIRE I and II in nine countries. EUROASPIRE I and II Group. European Action on Secondary Prevention by Intervention to Reduce Events. Lancet 2001;357:995-1001
   Google Scholar
• Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2003;290:199-206
   PubMed Web of Science ®Google Scholar
• Dubois RW, Alexander CM, Wade S, et al. Growth in use of lipid lowering therapies: are we targeting the right patients? Am J Manag Care 2002;8:862-7
   PubMed Web of Science ®Google Scholar
• Pearson TA, Laurora I, Chu H, et al. The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals. Arch Intern Med 2000;160:459-67
   PubMed Web of Science ®Google Scholar
• Ford ES, Mokdad AH, Giles WH, et al. Serum total cholesterol concentrations and awareness, treatment, and control of hypercholesterolemia among US adults: findings from the National Health and Nutrition Examination Survey, 1999 to 2000. Circulation 2003;107:2185-9
   PubMed Web of Science ®Google Scholar
• Johnson ML, Pietz K, Battleman DS, et al. Therapeutic goal attainment in patients with hypertension and dyslipidemia. Med Care 2006;44:39-46
   PubMed Web of Science ®Google Scholar
• PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement criteria, 2009. Available at: http://www.prisma-statement.org/ [Last assessed 28 January 2012]
   Google Scholar
• Andros V, Egger A, Dua U. Blood pressure goal attainment according to JNC 7 guidelines and utilization of antihypertensive drug therapy in MCO patients with type 1 or type 2 diabetes. J Manag Care Pharm 2006;12:303-9
   PubMed Web of Science ®Google Scholar
• Biskupiak JE, Kim J, Phatak H, et al. Prevalence of high-risk cardiovascular conditions and the status of hypertension management among hypertensive adults 65 years and older in the United States: analysis of a primary care electronic medical records database. J Clin Hypertens (Greenwich) 2010;12:935-44
   PubMed Web of Science ®Google Scholar
• Bisognano JD, Townsend KA, Skyles AJ, et al. Prevalence of comorbidities and their influence on blood pressure goal attainment in geriatric patients. Am J Geriatr Cardiol 2007;16:24-9
   PubMed Web of Science ®Google Scholar
• Bisognano JD, McLauhlin T, Roberts CS, et al. Calcium channel blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors: Effectiveness in combination with diuretics or β-blockers for treating hypertension. Vasc Health Risk Manag 2007;3:579-85
   PubMedGoogle Scholar
• Chang J, Yang W, Fellers T, et al. Chart review of patients on valsartan-based single-pill combinations vs. ARB-based free combinations for BP goal achievement. Curr Med Res Opin 2010;26:2203-12
   PubMed Web of Science ®Google Scholar
• Choe HM, Townsend KA, Blount G, et al. Treatment and control of blood pressure in patients with diabetes mellitus. Am J Health Syst Pharm 2007;64:97-103
   PubMed Web of Science ®Google Scholar
• Duggirala MK, Cuddihy RM, Cuddihy MT, et al. Predictors of blood pressure control in patients with diabetes and hypertension seen in primary care clinics. Am J Hypertens 2005;18:833-8
   PubMed Web of Science ®Google Scholar
• Gu Q, Burt VL, Paulose-Ram R, et al. Gender differences in hypertension treatment, drug utilization patterns, and blood pressure control among US adults with hypertension: data from the national health and nutrition examination survey 1999–2004. Am J Hypertens 2008;21:789-98
   PubMed Web of Science ®Google Scholar
• Kesarwani M, Perez A, Lopez VA, et al. Cardiovascular comorbidities and blood pressure control in stroke survivors. J Hypertens 2009;27:1056-63
   PubMed Web of Science ®Google Scholar
• Romanelli RJ, Schiro TA, Jukes T, et al. Disparities in blood pressure control within a community-based provider network: an exploratory analysis. Ann Pharmacother 2011;45:1473-82
   PubMed Web of Science ®Google Scholar
• Shelley D, Tseng TY, Andrews H, et al. Predictors of blood pressure control among hypertensives in community health centers. Am J Hypertens 2011;24:1318-23
   PubMed Web of Science ®Google Scholar
• Weycker D, Edelsberg J, Vincze G, et al. Blood pressure control in patients initiating antihypertensive therapy. Ann Pharmacother 2008;42:169-76
   PubMed Web of Science ®Google Scholar
• Bullano MF, Kamat S, Wertz DA, et al. Effectiveness of rosuvastatin versus atorvastatin in reducing lipid levels and achieving low-density-lipoprotein cholesterol goals in a usual care setting. Am J Health Syst Pharm 2007;64:276-84
   PubMed Web of Science ®Google Scholar
• Clark LT, Maki KC, Galant R, et al. Ethnic differences in achievement of cholesterol treatment goals. Results from the national cholesterol education program evaluation project utilizing novel E-technology II. J Gen Intern Med 2006;21:320-6
   PubMed Web of Science ®Google Scholar
• Cone C, Murata G, Myers O. Demographic determinants of response to statin medications. Am J Health Syst Pharm 2011;68:511-17
   PubMed Web of Science ®Google Scholar
• Fox KM, Gandhi SK, Ohsfeldt RL, et al. Effectiveness of rosuvastatin in low density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. Curr Med Res Opin 2007;23:2125-33
   PubMed Web of Science ®Google Scholar
• Friedman HS, Rajagopalan S, Barnes JP, et al. Combination therapy with ezetimibe/simvastatin versus statin monotherapy for low-density lipoprotein cholesterol reduction and goal attainment in a real-world clinical setting. Clin Ther 2011;33:212-24
   PubMed Web of Science ®Google Scholar
• Harley CR, Gandhi S, Blasetto J, et al. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins routine clinical practice. Am J Geriatr Pharmacother 2007;5:185-94
   PubMedGoogle Scholar
• Harley CR, Gandhi SK, Heien H, et al. Lipid levels and low-density lipoprotein cholesterol goal attainment in diabetic patients: rosuvastatin compared with other statins in usual care. Expert Opin Pharmacother 2008;9:669-76
   PubMed Web of Science ®Google Scholar
• Kamat SA, Gandhi SK, Davidson M. Comparative effectiveness of rosuvastatin versus other statin therapies in patients at increased risk of failure to achieve low density lipoprotein goals. Curr Med Res Opin 2007;23:1121-30
   PubMed Web of Science ®Google Scholar
• Kauffman AB, Olson KL, Youngblood ML, et al; Clinical Pharmacy Cardiac Risk Service Study Group. Attainment of low-density lipoprotein cholesterol goals in coronary artery disease. J Clin Lipidol 2010;4:173-80
   PubMed Web of Science ®Google Scholar
• Massing MW, Foley KA, Carter-Edwards L, et al. Disparities in lipid management for African-Americans and Caucasians with coronary artery disease: a national cross-sectional study. BMC Cardiovasc Disord 2004;4:15
   PubMedGoogle Scholar
• Mosca L, Merz NB, Blumenthal RS, et al. Opportunity for intervention to achieve American heart association guidelines for optimal lipid levels in high-risk women in a managed care setting. Circulation 2005;111:488-93
   PubMed Web of Science ®Google Scholar
• Nichols GA, Ambegaonkar BM, Sazonov V, et al. Frequency of obtaining national cholesterol education program adult treatment panel III goals for all major serum lipoproteins after initiation of lipid altering therapy. Am J Cardiol 2009;104:1689-94
   PubMed Web of Science ®Google Scholar
• Putzer G, Roetzheim R, Ramirez AM, et al. Compliance with recommendations for lipid management among patients with type 2 diabetes in an academic family practice. J Am Board Fam Pract 2004;17:101-7
   PubMedGoogle Scholar
• Stadler SL, Bhardwaja B, Olson KL, et al. An assessment of cholesterol goal attainment in patients with chronic kidney disease. J Clin Lipidol 2010;4:298-304
   PubMed Web of Science ®Google Scholar
• Virani SS, Woodard LD, Landrum CR, et al. Institutional, provider, and patient correlates of low-density lipoprotein and non-high-density lipoprotein cholesterol goal attainment according to the adult treatment panel III guidelines. Am Heart J 2011;161:1140-6
   PubMed Web of Science ®Google Scholar
• Ahluwalia IB, Tessaro I, Greenlund KJ, et al. Factors associated with control of hypertension, hypercholesterolemia, and diabetes among low-income women in West Virginia. J Womens Health (Larchmt) 2010;19:417-24
   PubMed Web of Science ®Google Scholar
• Federman DG, Krishnamurthy R, Kancir S, et al. Relationship between provider type and the attainment of treatment goals in primary care. Am J Manag Care 2005;11:561-6
   PubMed Web of Science ®Google Scholar
• McDonald M, Hertz RP, Unger AN, et al. Prevalence, awareness, and management of hypertension, dyslipidemia, and diabetes among United States adults aged 65 and older. J Gerontol A Biol Sci Med Sci 2009;64:256-63
   PubMed Web of Science ®Google Scholar
• Welch V, Tang SS. Treatment and control of BP and lipids in patients with hypertension and additional risk factors. Am J Cardiovasc Drugs 2007;7:381-9
   PubMed Web of Science ®Google Scholar
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med 1997;157:2413-46
   Google Scholar
• National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). Circulation 1994;89:1333-445
   Google Scholar
• Brunzell JD, Davidson MH, Furberg CD, et al. Lipoprotein management in patients with cardio-metabolic risk: consensus statement from the American Diabetes Association and the American College of Cardiology Foundation. Diabetes Care 2008;31:811-22
   PubMed Web of Science ®Google Scholar
• Smith SC Jr, Benjamin EJ, Bonow RO, et al. AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update. A guideline from the American Heart Association and American College of Cardiology Foundation. Circulation 2011;124:2458-73
   PubMed Web of Science ®Google Scholar